Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)

计划入组 69 人 · 首次发布于 2019 年 7 月 16 日

CTLA-4 and PD-1 Antibodies Expressing MUC1-CAR-T Cells for MUC1 Positive Advanced Solid Tumor

计划入组 40 人 · 首次发布于 2017 年 6 月 7 日

Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor

计划入组 20 人 · 首次发布于 2015 年 10 月 27 日

HSP-MUC1

UCART-MUC1

PDS-0103

MUC Research GmbH

Germany

FDA Clears PDS Biotech's Novel Immunotherapy Combination for Metastatic Colorectal Cancer Trial

PDS Biotechnology Secures New Japanese Patent for Cancer Immunotherapy PDS0101, Extending Protection Into 2040s

PDS Biotech's Versamune Shows Promise in HPV-Positive Cancers